Journal of Diabetes and Its Complications
Volume 19, Issue 1 , Pages 1-9 , January 2005

The Family Investigation of Nephropathy and Diabetes (FIND) Design and methods

  • On behalf of the Family Investigation of Nephropathy and Diabetes Research Group

      Affiliations

    • The members are listed in Appendix.
    • ,
  • William C. Knowler

      Affiliations

    • Diabetes and Arthritis Epidemiology Section, National Institute of Diabetes and Digestive and Kidney Diseases, Phoenix, AZ, USA
    • ,
  • Josef Coresh

      Affiliations

    • Department of Epidemiology Biostatistics and Medicine, Johns Hopkins University, Baltimore MD, USA
    • ,
  • Robert C. Elston

      Affiliations

    • Corresponding Author InformationCorresponding author. Tel.: +1-216-778-3863; fax: +1-216-778-3280
    • Department of Genetic Epidemiology and Biostatistics, MetroHealth Medial Center, Case Western Reserve University, 2500 MetroHealth Drive, Rammelkamp 258, Cleveland, OH 44109, USA
    • ,
  • Barry I. Freedman

      Affiliations

    • Department of Internal Medicine—Nephrology, Wake Forest University, Winston-Salem, NC, USA
    • ,
  • Sudha K. Iyengar

      Affiliations

    • Department of Genetic Epidemiology and Biostatistics, MetroHealth Medial Center, Case Western Reserve University, 2500 MetroHealth Drive, Rammelkamp 258, Cleveland, OH 44109, USA
    • ,
  • Paul L. Kimmel

      Affiliations

    • Diabetic Nephropathy and HIV Programs, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD, USA
    • ,
  • Jane M. Olson

      Affiliations

    • Department of Genetic Epidemiology and Biostatistics, MetroHealth Medial Center, Case Western Reserve University, 2500 MetroHealth Drive, Rammelkamp 258, Cleveland, OH 44109, USA
    • ,
  • Rosemarie Plaetke

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Texas Health Sciences Center at San Antonio, San Antonio, TX, USA
    • ,
  • John R. Sedor

      Affiliations

    • Rammelkamp Center for Research and Education, Case Western Reserve University, Cleveland, OH, USA
    • ,
  • Michael F. Seldin

      Affiliations

    • Department of Biological Chemistry and Medicine, University of California, Davis, Davis, CA, USA

Received 25 June 2003 ,Revised 20 December 2003 ,Accepted 31 December 2003.

References 

  1. Araki S, Makita Y, Canani L, Ng D, Warram JH, Krolewski AS. Polymorphisms of human paraoxonase 1 gene (PON1) and susceptibility to diabetic nephropathy in type I diabetes mellitus. Diabetologia. 2000;43:1540–1543
  2. Araki S, Moczulski DK, Hanna L, Scott LJ, Warram JH, Krolewski AS. APOE polymorphisms and the development of diabetic nephropathy in type 1 diabetes: results of case–control and family-based studies. Diabetes. 2000;49:2190–2195
  3. Blackemore AI, Cox A, Gonzalez AM. Interleukin-1 receptor antagonist allele (ILIRN*2) associated with nephropathy in diabetes mellitus. Human Genetics. 1996;97:369–374
  4. Brenner BM, Cooper ME, Zeeuw DD, Keane WF, Mitch WE, Parving HH, et al. Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. New England Journal of Medicine. 2001;345:861–869
  5. Canani LH, Gerchman F, Gross JL. Familial clustering of diabetic nephropathy in Brazilian type 2 diabetic patients. Diabetes. 1999;48:909–913
  6. Chakraborty R. Gene admixture in human populations: models and predictions. Yearbook of Physical Anthropology. 1986;29:1–43
  7. Collins-Schramm HE, Kittles RA, Operario DJ, Weber JL, Criswell LA, Cooper RS, et al. Markers that discriminate between European and African ancestry show limited variation within Africa. Human Genetics. 2002;111:566–569
  8. Collins-Schramm HE, Phillips CM, Operario DJ, Lee JS, Weber JL, Hanson RL, et al. Ethnic-difference markers for use in mapping by admixture linkage disequilibrium. American Journal of Human Genetics. 2002;70:737–750
  9. Early Treatment Diabetic Retinopathy Study Research Group . Grading diabetic retinopathy from stereoscopic color fundus photographs—an extension of the modified Airlie House classification. ETDRS Report Number 10. Ophthalmology. 1991;98(Suppl.):807–822
  10. Elston RC. Linkage and association. Genetic Epidemiology. 1998;15:565–576
  11. Elston RC, Guo X, Williams LV. Two-stage global search designs for linkage analysis using pairs of affected relatives. Genetic Epidemiology. 1996;13:535–558
  12. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care. 1997;20:1183–1197
  13. Freedman BI, Tuttle AB, Spray BJ. Familial predisposition to nephropathy in African-Americans with non-insulin-dependent diabetes mellitus. American Journal of Kidney Diseases. 1995;25:710–713
  14. Freedman BI, Yu H, Anderson PJ, Roh BH, Rich SS, Bowden DW. Genetic analysis of nitric oxide synthase and endothelin in end-stage renal disease. Nephrology Dialysis Transplantation. 2000;15:1794–1800
  15. Freedman BI, Yu H, Spray BJ, Rich SS, Rothschild CB, Bowden DW. Genetic linkage analysis of growth factor loci and end-stage renal disease in African Americans. Kidney International. 1997;51:819–825
  16. Fujisawa T, Ikegami H, Kawaguchi Y, Hamada Y, Ueda H, Shintani M, et al. Meta-analysis of association of insertion/deletion polymorphism of angiotensin 1-converting enzyme gene with diabetic nephropathy and retinopathy. Diabetologia. 1998;41:47–53
  17. George VT, Elston RC. Testing the association between polymorphic markers and quantitative traits in pedigrees. Genetic Epidemiology. 1987;4:193–201
  18. George VT, Elston RC, Amos CI, Ward LJ, Berenson GS. Association between polymorphic blood markers and risk factors for cardiovascular disease in a large pedigree. Genetic Epidemiology. 1987;4:267–275
  19. Haffner SM, Mitchell BD, Pugh JA, Stern MP, Kozlowski MK, Hazuda HP, et al. Proteinuria in Mexican Americans and non-Hispanic whites with NIDDM. Diabetes Care. 1989;12:530–536
  20. In:  Haines JL,  Pericak-Vance MA editor. Approaches to gene mapping in complex human diseases. New York: John Wiley and Sons; 1998;
  21. Hall JM, LeDuc CA, Watson AR, Roter AH. An approach to high-throughput genotyping. Genome Research. 1996;6:781–790
  22. Imperatore G, Hanson RL, Pettitt DJ, Kobes S, Bennett PH, Knowler WC. Sib-pair linkage analysis for susceptibility genes for microvascular complications among Pima Indians with type 2 diabetes mellitus. Diabetes. 1998;47:821–830
  23. Imperatore G, Knowler WC, Pettitt DJ, Kobes S, Bennett PH, Hanson RL. Segregation analysis of diabetic nephropathy in Pima Indians. Diabetes. 2000;49:1049–1056
  24. Krolewski AS. Genetics of diabetic nephropathy: evidence for major and minor gene effects. Kidney International. 1999;55:1582–1596
  25. Kunz R, Bork JP, Fritsche L, Ringel J, Sharma A. Association between the angiotensin-converting enzyme—Insertion/deletion polymorphism and diabetic nephropathy: a methodologic appraisal and systematic review. Journal of the American Society of Nephrology. 1998;9:1653–1663
  26. Kunzelman CL, Knowler WC, Pettitt DJ, Bennett PH. Incidence of proteinuria in type 2 diabetes mellitus in the Pima Indians. Kidney International. 1989;35:681–687
  27. Lautenberger JA, Stephens JC, O'Brien SJ, Smith MW. Significant admixture linkage disequilibrium across 30 cM around the FY locus in African Americans. American Journal of Human Genetics. 2000;66:969–978
  28. Lewis EJ, Hunsicker LG, Clarke WR, Berl T, Pohl MA, Lewis JB, et al. Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. New England Journal of Medicine. 2001;345:851–860
  29. McKeigue PM. Mapping genes that underlie ethnic differences in disease risk: methods for detecting linkage in admixed populations, by conditioning on parental admixture. American Journal of Human Genetics. 1998;63:241–251
  30. Moczulski DK, Rogus JJ, Antonellis A, Warram JH, Krolewski AS. Major susceptibility locus for nephropathy in type 1 diabetes on chromosome 3q: results of novel discordant sib-pair analysis. Diabetes. 1998;47:1164–1169
  31. Moczulski DK, Scott L, Antonellis A, Rogus JJ, Rich SS, Warram JH, et al. Aldose reductase gene polymorphisms and susceptibility to diabetic nephropathy in type 1 diabetes mellitus. Diabetic Medicine. 2000;17:111–118
  32. Nelson RG, Knowler WC, Pettitt DJ, Saad MF, Charles MA, Bennett PH. Assessment of risk of overt nephropathy in diabetic patients from albumin excretion in untimed urine specimens. Archives of Internal Medicine. 1991;151:1761–1765
  33. Parra EJ, Marcini A, Akey J, Martinson J, Batzer MA, Cooper R, et al. Estimating African American admixture proportions by use of population specific alleles. American Journal of Human Genetics. 1998;63:1839–1851
  34. Parving H, Lehnert H, Brochner-Mortensen J, Gomis R, Andersen S, Arner P. The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes. New England Journal of Medicine. 2001;345:870–878
  35. Perneger TV, Whelton PK, Klag MJ. Race and end-stage renal disease: socioeconomic status and access to health care as mediating factors. Archives of Internal Medicine. 1995;155:1201–1208
  36. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Knowler WC. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin-dependent) diabetes mellitus. Diabetologia. 1990;33:438–443
  37. Pfaff CL, Parra EJ, Bonilla C, Hiester K, McKeigue PM, Kamboh MI, et al. Population structure in admixed populations: effect of admixture dynamics on the pattern of linkage disequilibrium. American Journal of Human Genetics. 2001;68:198–207
  38. Pugh JA, Stem MP, Haffner SM, Eifler CW, Zapata M. Excess incidence of treatment of end-stage renal disease in Mexican Americans. American Journal of Epidemiology. 1988;127:135–144
  39. Quinn M, Angelico MC, Warram JH, Krolewski AS. Familial factors determine the development of diabetic nephropathy in patients with IDDM. Diabetologia. 1996;39:940–945
  40. In:  Rao DC,  Province MA editor. Genetic dissection of complex traits. New York: Academic Press; 2001;
  41. Rife DC. Population of hybrid origin as source material for the detection of linkage. American Journal of Human Genetics. 1954;6:26–32
  42. Rogus JJ, Moczulski D, Freire MB, Yang Y, Warram JH, Krolewski AS. Diabetic nephropathy is associated with AGT polymorphism T235: results of a family-based study. Hypertension. 1998;31:627–631
  43. S.A.G.E. Statistical Analysis for Genetic Epidemiology: Release 3.1, DESPAIR. Available at: http://darwin.cwru.edu/despair/index.php.
  44. Seaquist ER, Goetz FC, Rich SS, Barbosa J. Familial clustering of diabetic kidney disease: evidence for genetic susceptibility to diabetic nephropathy. New England Journal of Medicine. 1989;320:1161–1165
  45. Smith MW, Lautenberger JA, Doo Shin H, Chretien JP, Shrestha S, Gilbert DA, et al. Markers for mapping by admixture linkage disequilibrium in African American and Hispanic populations. American Journal of Human Genetics. 2001;69:1080–1094
  46. Spielman RS, Ewens WJ. A sibship test for linkage in the presence of association: the sib transmission disequilibrium test. American Journal of Human Genetics. 1998;62:450–458
  47. Stephens JC, Briscoe D, O'Brien SJ. Mapping by admixture linkage disequilibrium in human populations: limits and guidelines. American Journal of Human Genetics. 1994;55:809–824
  48. The Diabetes Control and Complications Trial Research Group . The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. New England Journal of Medicine. 1993;329:977–986
  49. The Family Investigation of Nephropathy and Diabetes Research Group . Genetic determinants of diabetic nephropathy: the Family Investigation of Nephropathy and Diabetes (FIND). Journal of the American Society of Nephrology. 2003;14:S202–S204
  50. UK Prospective Diabetes Study (UKPDS) Group . Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet. 1998;352:837–853
  51. US Renal Data System (2002). USRDS 2002 annual data report: Atlas of end-stage renal disease in the United States. National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, Bethesda, MD. Available at: http://www.usrds.org/.
  52. Vardali I, Baier LJ, Hanson RL, Akkoyun I, Fischer C, Rohmeiss P, et al. Gene for susceptibility to diabetic nephropathy in type 2 diabetes maps to 18q22.3-23. Kidney International. 2002;62:2276–2283
  53. Whittle JC, Whelton PK, Seidler AJ, Klag MJ. Does racial variation in risk factors explain black–white differences in the incidence of hypertensive end-stage renal disease?. Archives of Internal Medicine. 1991;151:1359–1364
  54. Yu H, Anderson PJ, Freedman BI, Rich SS, Bowden DW. Genomic structure of the human plasma prekallikrein gene, identification of allelic variants, and analysis in end-stage renal disease. Genomics. 2000;69:225–234
  55. Yu H, Bowden DW, Spray BJ, Rich SS, Freedman BI. Linkage analysis between loci in the renin angiotensin axis and end-stage renal disease in African Americans. Journal of the American Society of Nephrology. 1996;7:2559–2564
  56. Yu H, Freedman BI, Rich SS, Bowden DW. Human Na/H exchanger genes NHE1, 2, 3, 5: identification of polymorphisms by radiation hybrid mapping and analysis of linkage in end-stage renal disease. Hypertension. 2000;35:135–143
  57. Zanchi A, Moczulski DK, Hanna LS, Wantman M, Warram JH, Krolewski AS. Risk of advanced diabetic nephropathy in type I diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney International. 2000;57:405–413
  58. Zheng C, Elston RC. Multipoint linkage disequilibrium mapping with particular reference to the African-American population. Genetic Epidemiology. 1999;17:79–101
  59. Ziegle JS, Su Y, Corcoran KP, Nie L, Mayrand PE, Hoff LB, et al. Application of automated DNA sizing technology for genotyping microsatellite loci. Genomics. 1992;14:1026–1031

PII: S1056-8727(04)00002-9

doi: 10.1016/j.jdiacomp.2003.12.007

Journal of Diabetes and Its Complications
Volume 19, Issue 1 , Pages 1-9 , January 2005

Article Tools